These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20816833)

  • 1. Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD.
    Cazzola M; Pasqua F; Ferri L; Biscione G; Cardaci V; Matera MG
    Pulm Pharmacol Ther; 2011 Feb; 24(1):118-22. PubMed ID: 20816833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.
    Cazzola M; Noschese P; De Michele F; D'Amato G; Matera MG
    Respir Med; 2006 Feb; 100(2):212-7. PubMed ID: 15936184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD.
    Cazzola M; Santus P; Di Marco F; Carlucci P; Mondoni M; Matera MG; Centanni S
    Pulm Pharmacol Ther; 2004; 17(3):121-5. PubMed ID: 15123220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.
    Calverley PM; Kuna P; Monsó E; Costantini M; Petruzzelli S; Sergio F; Varoli G; Papi A; Brusasco V
    Respir Med; 2010 Dec; 104(12):1858-68. PubMed ID: 20965712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
    Celli BR; Tashkin DP; Rennard SI; McElhattan J; Martin UJ
    Respir Med; 2011 Aug; 105(8):1176-88. PubMed ID: 21531124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.
    Fukuchi Y; Samoro R; Fassakhov R; Taniguchi H; Ekelund J; Carlsson LG; Ichinose M
    Respirology; 2013 Jul; 18(5):866-73. PubMed ID: 23551359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.
    Papi A; Paggiaro PL; Nicolini G; Vignola AM; Fabbri LM;
    Eur Respir J; 2007 Apr; 29(4):682-9. PubMed ID: 17107988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.
    Worth H; Förster K; Eriksson G; Nihlén U; Peterson S; Magnussen H
    Respir Med; 2010 Oct; 104(10):1450-9. PubMed ID: 20692140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
    Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
    Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
    Palmqvist M; Arvidsson P; Beckman O; Peterson S; Lötvall J
    Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.
    Welte T; Miravitlles M; Hernandez P; Eriksson G; Peterson S; Polanowski T; Kessler R
    Am J Respir Crit Care Med; 2009 Oct; 180(8):741-50. PubMed ID: 19644045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia.
    Chuchalin AG; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Int J Clin Pract; 2002; 56(1):15-20. PubMed ID: 11833550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler.
    Cazzola M; Matera MG; D'Amato M; Califano C; Sanduzzi A; Vatrella A; D'Amato G
    Pulm Pharmacol Ther; 2003; 16(2):105-9. PubMed ID: 12670779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease.
    Zhong N; Zheng J; Wen F; Yang L; Chen P; Xiu Q; Yao W; Sun T; Zhao Z; Shen H; Shi Y; Lin J; Li Q
    Curr Med Res Opin; 2012 Feb; 28(2):257-65. PubMed ID: 22046961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.
    Wedzicha JA; Singh D; Vestbo J; Paggiaro PL; Jones PW; Bonnet-Gonod F; Cohuet G; Corradi M; Vezzoli S; Petruzzelli S; Agusti A;
    Respir Med; 2014 Aug; 108(8):1153-62. PubMed ID: 24953015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.